眼底血管荧光造影在评估视网膜挫伤预后方面临床研究  

The clinical study of retinal blood vessels fluorescence imaging in the evaluation of prognosis of retinal contusion

作　　者：陈硕[1] 郭娴吟[1] 曹征[1] 黎锦萍 

机构地区：[1]广东省东莞市石龙人民医院,广东东莞523320

出　　处：《中国医药科学》2014年第15期74-76,共3页China Medicine And Pharmacy

摘　　要：目的评价眼底血管荧光造影(FFA)在视网膜挫伤预后评价中的应用。方法选取视网膜挫伤患者51例为研究对象,分别采用视觉诱发电位(VEP)、FFA进行检查,并全部随访51例患者的视力变化。结果挫伤的眼睛其VEP P100波振幅明显降低,潜伏期明显延迟;治疗后VEP P100波振幅、潜伏期均明显改善(P<0.05);FFA检查混合性损伤32眼,单纯性损伤19眼,其中38眼表现为视网膜震荡,14眼表现为视网膜出血,5眼表现为脉络膜裂伤,4眼表现为黄斑裂孔,8眼表现为视神经挫伤。治疗后1个月复查眼底血管荧光造影显示,51眼中,视盘渗漏1眼,周边视网膜血管仍有渗漏者3眼,视网膜新生血管未退行1眼。结论 VEP、F-ERG及FFA检查均可对眼挫伤患者进行有效的诊断及预后评估,临床应用中可根据患者情况联合或单独应用。Objective To evaluate the application of retinal blood vessels fluorescence angiography（ FFA） in the evaluation of prognosis of retinal contusion . Methods 51 patients with retinal contusion were selected as the research objects,who were respectively used visual evoked potential（ the VEP）, FFA for inspection,and all were followed up the changes in vision. Results The VEP amplitude of P100 waves of the eyes of the contusion was significantly low,the incubation period was significantly delayed;The VEP amplitude of P100 waves after treatment,the incubation period were both significantly improved（P 〈 0.05）; 32 eyes of mixed injury were given FFA examination,19 eyes of simple injury,38 eyes among them showed commotio retinae,14 eyes showed retinal hemorrhage,five eyes showed choroid laceration,4 eyes showed macular hole,8 eyes showed optic nerve contusion. After treatment,fluorescence imaging showed review retinal blood vessels within 1 month,among 51 eyes,one eye was leakage of optic disk,three eyes were still leakage of peripheral retinal blood vessels,one eye was retinal neovascularization without regression. Conclusion The VEP,F- ERG and FFA examination can efficiently evaluate the diagnosis and prognosis to the patients of eye contusion,according to individual treatment schemes,they can be combined or applied independently by VEP、 F-ERG and FFA examinations.

关 键 词：视网膜挫伤 眼底血管荧光造影 预后 评估 

分 类 号：R779.1[医药卫生—眼科]